Bukwang Pharm Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bukwang Pharm Co Ltd with three other
companies in this sector in KOREA (SOUTH) :
Celltrion Pharm Incorporated
sales of 173.51 billion Korean Won [US$145.58 million]
of which 38%
was Godex Cap),
Whanin Pharmaceutical Company Limited
(159.18 billion Korean Won [US$133.55 million]
of which 100%
was Medicine & Medical Supplies), and
JW Life Science Corp
(170.22 billion Korean Won [US$142.82 million]
During the year ended December of 2019, sales at
Bukwang Pharm Co Ltd were 168.19 billion Korean Won (US$141.11 million).
decrease of 13.4%
versus 2018, when the company's sales were 194.22 billion Korean Won .